BREAKING

Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 8 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 9 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 9 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 10 hours ago Atmus Welcomes Heath Sharp to Board of Directors 12 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 12 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 8 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 9 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 9 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 10 hours ago Atmus Welcomes Heath Sharp to Board of Directors 12 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 12 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago

ADVERTISEMENT

Market News

AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call

AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice President and Chief Financial Analysts: Jayson T. Bedford — Raymond James — Analyst Matthew I. Mishan — KeyBanc Capital Markets — Analyst Bill J. Plovanic — Canaccord Genuity — Analyst _________ To read the full earnings call transcript, click here

$ANGO January 8, 2021 1 min read

AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021

Corporate Participants:

Jim Clemmer — President and Chief Executive

Stephen A. Trowbridge — Executive Vice President and Chief Financial

Analysts:

Jayson T. Bedford — Raymond James — Analyst

Matthew I. Mishan — KeyBanc Capital Markets — Analyst

ADVERTISEMENT

Bill J. Plovanic — Canaccord Genuity — Analyst

_________
To read the full earnings call transcript, click here

ADVERTISEMENT